Mochida Pharmaceutical Co Forecast, price target & analysts

2 Analysts have issued a sales forecast Mochida Pharmaceutical Co 2027 . The average Mochida Pharmaceutical Co sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

2 Mochida Pharmaceutical Co Analysts have issued a net profit forecast 2027. The average Mochida Pharmaceutical Co net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

2 Analysts have issued a Mochida Pharmaceutical Co forecast for earnings per share. The average Mochida Pharmaceutical Co EPS is

. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Based on analysts' sales estimates for 2027, the Mochida Pharmaceutical Co stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

Mochida Pharmaceutical Co...